Please login to the form below

Not currently logged in
Email:
Password:

malignant glioma

This page shows the latest malignant glioma news and features for those working in and with pharma, biotech and healthcare.

BMS signs $1.74bn deal to boost immuno-oncology portfolio

BMS signs $1.74bn deal to boost immuno-oncology portfolio

malignant cells. ... and malignant glioma.

Latest news

  • BMS' Opdivo set for early access in UK BMS' Opdivo set for early access in UK

    Until now, the only PIM granted under the scheme was for Northwest Biotherapeutics' cell-based therapy DCVax-L for a form of brain cancer known as malignant glioma.

  • FDA grants orphan status to Activartis’ brain cancer immunotherapy FDA grants orphan status to Activartis’ brain cancer immunotherapy

    FDA grants orphan status to Activartis’ brain cancer immunotherapy. Regulator says AV0113 has potential in rare cancer malignant glioma. ... The Austria-based biotech said the US regulator gave the designation for AV0113's use in the treatment

  • Roche's Avastin gains Japanese approval for brain cancer Roche's Avastin gains Japanese approval for brain cancer

    The Japanese drug regulator has approved Roche's Avastin (bevacizumab) for malignant glioma and newly diagnosed glioblastoma (GBM), in combination with radiotherapy and temozolomide chemotherapy. ... The estimated number of newly diagnosed malignant

  • Ark files documentation on Cerepro

    gene-based therapy for the treatment of operable malignant glioma (brain cancer). ... Malignant glioma is a fatal form of brain tumour that is usually confined to the brain.

  • Close but no cigar

    Both are being reviewed by the EMEA for the treatment of head and neck cancer and glioma, respectively. ... glioma, compared with patients receiving standard care alone (either surgery and radiotherapy or surgery and radiotherapy plus temozolomide).

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics